ABSCI CORP Increase (Decrease) in Contract with Customer, Liability
ABSCI CORP (ABSI) reported Increase (Decrease) in Contract with Customer, Liability of $218.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-11
- ABSCI CORP increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $301.00K.
- ABSCI CORP increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$83.00K.
- ABSCI CORP increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$401.00K.
- ABSCI CORP increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $622.00K.
- ABSCI CORP increase (decrease) in contract with customer, liability for fiscal 2025 was $59.00K.
- ABSCI CORP increase (decrease) in contract with customer, liability for fiscal 2024 was -$3.02M, a 181.84% decline from fiscal 2023.
- ABSCI CORP increase (decrease) in contract with customer, liability for fiscal 2023 was $3.69M.
- ABSCI CORP increase (decrease) in contract with customer, liability for fiscal 2022 was -$907.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $218.00K 10-Q · filed 2026-08-11 | -$183.00K derived: sum of 3 quarters · filed 2026-08-11 | $439.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$83.00K 10-Q · filed 2026-05-07 | -$484.00K derived: sum of 2 quarters · filed 2026-05-07 | $138.00K derived: sum of 3 quarters · filed 2026-05-07 | -$4.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $221.00K derived: sum of 2 quarters · filed 2026-03-24 | $79.00K derived: sum of 3 quarters · filed 2026-08-11 | $59.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $622.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $480.00K derived: sum of 2 quarters · filed 2026-08-11 | $460.00K 10-Q · filed 2025-11-12 | -$205.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$162.00K 10-Q · filed 2026-08-11 | -$827.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.02M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$20.00K 10-Q · filed 2026-05-07 | -$685.00K derived: sum of 2 quarters · filed 2026-05-07 | -$876.00K derived: sum of 3 quarters · filed 2026-05-07 | -$2.15M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$665.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$856.00K derived: sum of 2 quarters · filed 2026-03-24 | -$2.13M derived: sum of 3 quarters · filed 2026-03-24 | -$3.02M 10-K · filed 2026-03-24 |
| 2024-09-30 | -$191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.46M derived: sum of 2 quarters · filed 2025-11-12 | -$2.36M 10-Q · filed 2025-11-12 | $1.44M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.17M 10-Q · filed 2025-08-12 | $1.63M derived: sum of 3 quarters · filed 2025-08-12 | $1.47M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$898.00K 10-Q · filed 2025-05-13 | $2.90M derived: sum of 2 quarters · filed 2025-05-13 | $2.74M derived: sum of 3 quarters · filed 2025-05-13 | $2.88M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $3.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $3.64M derived: sum of 2 quarters · filed 2025-03-18 | $3.78M derived: sum of 3 quarters · filed 2025-03-18 | $3.69M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$14.00K derived: sum of 2 quarters · filed 2024-11-12 | -$100.00K 10-Q · filed 2024-11-12 | -$333.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $55.00K 10-Q · filed 2024-08-14 | -$178.00K derived: sum of 3 quarters · filed 2024-08-14 | -$2.30M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$86.00K 10-Q · filed 2024-05-14 | -$319.00K derived: sum of 2 quarters · filed 2024-05-14 | -$2.44M derived: sum of 3 quarters · filed 2024-05-14 | -$2.43M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$2.35M derived: sum of 2 quarters · filed 2024-03-21 | -$2.35M derived: sum of 3 quarters · filed 2024-03-21 | -$907.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.11M derived: sum of 2 quarters · filed 2023-11-14 | -$674.00K 10-Q · filed 2023-11-14 | -$1.41M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.44M 10-Q · filed 2023-08-14 | $706.00K derived: sum of 3 quarters · filed 2023-08-14 | $183.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.44M 10-Q · filed 2023-05-15 | $700.00K derived: sum of 2 quarters · filed 2023-05-15 | $177.00K derived: sum of 3 quarters · filed 2023-05-15 | $388.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$738.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.26M derived: sum of 2 quarters · filed 2023-03-30 | -$1.05M derived: sum of 3 quarters · filed 2023-03-30 | -$1.28M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$312.00K derived: sum of 2 quarters · filed 2022-11-09 | -$539.00K 10-Q · filed 2022-11-09 | $1.14M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$16.00K 10-Q · filed 2022-08-11 | $1.67M derived: sum of 3 quarters · filed 2022-08-11 | $1.90M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$227.00K 10-Q · filed 2022-05-11 | $1.45M derived: sum of 2 quarters · filed 2022-05-11 | $1.69M derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.92M derived: sum of 2 quarters · filed 2022-03-22 | $1.85M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $239.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $169.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$70.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |